Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin
Abstract Fisetin is one of the most popular flavonoids found in vegetables and fruits with several health benefits such as antidiabetic, anticancer, and anti‐inflammatory activities. Biotechnology or chemosynthesis tools were used for the synthesis of fisetin and its analogs to improve their yield a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-04-01
|
| Series: | eFood |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/efd2.3 |
| _version_ | 1811185728970817536 |
|---|---|
| author | Ruting Zhong Mohamed A. Farag Meiwan Chen Chengwei He Jianbo Xiao |
| author_facet | Ruting Zhong Mohamed A. Farag Meiwan Chen Chengwei He Jianbo Xiao |
| author_sort | Ruting Zhong |
| collection | DOAJ |
| description | Abstract Fisetin is one of the most popular flavonoids found in vegetables and fruits with several health benefits such as antidiabetic, anticancer, and anti‐inflammatory activities. Biotechnology or chemosynthesis tools were used for the synthesis of fisetin and its analogs to improve their yield and efficacy. Structure activity relationships (SARs) revealed that the aromatic hydroxyl groups especially the 3,4‐dihydroxylation at ring B were crucial for fisetin biological activities, whereas substitution of several hydroxyl groups in fisetin appeared to impact its original effects. The ongoing or upcoming clinical trials containing fisetin are applied in drugs and dietary supplements. Noteworthily, fisetin has been successfully incorporated into nutraceuticals in the market. Furthermore, the delivery system of fisetin‐loaded nanocochleates showed the best bioavailability compared to other formulations. This review presents the latest research progress of fisetin on its synthesis, structure–activity relationships, pharmacokinetics, biological activities, and underlying mechanisms, bioavailability, delivery systems, and clinical trials to provide a comprehensive insight into the research and application of this valuable natural compound. |
| first_indexed | 2024-04-11T13:34:08Z |
| format | Article |
| id | doaj.art-423b0b8b87a94516bb487e1f49e3416c |
| institution | Directory Open Access Journal |
| issn | 2666-3066 |
| language | English |
| last_indexed | 2024-04-11T13:34:08Z |
| publishDate | 2022-04-01 |
| publisher | Wiley |
| record_format | Article |
| series | eFood |
| spelling | doaj.art-423b0b8b87a94516bb487e1f49e3416c2022-12-22T04:21:37ZengWileyeFood2666-30662022-04-0131-2n/an/a10.1002/efd2.3Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetinRuting Zhong0Mohamed A. Farag1Meiwan Chen2Chengwei He3Jianbo Xiao4Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine University of Macau Macau ChinaPharmacognosy Department, College of Pharmacy Cairo University Cairo EgyptInstitute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine University of Macau Macau ChinaInstitute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine University of Macau Macau ChinaDepartment of Analytical and Food Chemistry, Faculty of Sciences Universidade de Vigo Ourense SpainAbstract Fisetin is one of the most popular flavonoids found in vegetables and fruits with several health benefits such as antidiabetic, anticancer, and anti‐inflammatory activities. Biotechnology or chemosynthesis tools were used for the synthesis of fisetin and its analogs to improve their yield and efficacy. Structure activity relationships (SARs) revealed that the aromatic hydroxyl groups especially the 3,4‐dihydroxylation at ring B were crucial for fisetin biological activities, whereas substitution of several hydroxyl groups in fisetin appeared to impact its original effects. The ongoing or upcoming clinical trials containing fisetin are applied in drugs and dietary supplements. Noteworthily, fisetin has been successfully incorporated into nutraceuticals in the market. Furthermore, the delivery system of fisetin‐loaded nanocochleates showed the best bioavailability compared to other formulations. This review presents the latest research progress of fisetin on its synthesis, structure–activity relationships, pharmacokinetics, biological activities, and underlying mechanisms, bioavailability, delivery systems, and clinical trials to provide a comprehensive insight into the research and application of this valuable natural compound.https://doi.org/10.1002/efd2.3bioactivitiesbioavailabilityclinical trialsfisetinformulationsmolecular mechanism |
| spellingShingle | Ruting Zhong Mohamed A. Farag Meiwan Chen Chengwei He Jianbo Xiao Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin eFood bioactivities bioavailability clinical trials fisetin formulations molecular mechanism |
| title | Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin |
| title_full | Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin |
| title_fullStr | Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin |
| title_full_unstemmed | Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin |
| title_short | Recent advances in the biosynthesis, structure–activity relationships, formulations, pharmacology, and clinical trials of fisetin |
| title_sort | recent advances in the biosynthesis structure activity relationships formulations pharmacology and clinical trials of fisetin |
| topic | bioactivities bioavailability clinical trials fisetin formulations molecular mechanism |
| url | https://doi.org/10.1002/efd2.3 |
| work_keys_str_mv | AT rutingzhong recentadvancesinthebiosynthesisstructureactivityrelationshipsformulationspharmacologyandclinicaltrialsoffisetin AT mohamedafarag recentadvancesinthebiosynthesisstructureactivityrelationshipsformulationspharmacologyandclinicaltrialsoffisetin AT meiwanchen recentadvancesinthebiosynthesisstructureactivityrelationshipsformulationspharmacologyandclinicaltrialsoffisetin AT chengweihe recentadvancesinthebiosynthesisstructureactivityrelationshipsformulationspharmacologyandclinicaltrialsoffisetin AT jianboxiao recentadvancesinthebiosynthesisstructureactivityrelationshipsformulationspharmacologyandclinicaltrialsoffisetin |